Related Experiment Videos
[Peripheral centrofacial T lymphoma]
R Vera Llao1, J Girons Bonells, T Serrano Piñol
1Servicio de ORL, L'Hospitalet de Llobregat, Barcelona.
Acta Otorrinolaringologica Espanola
|May 1, 1996
Summary
Distinguishing Wegener's granulomatosis from destructive facial lesions is challenging. A case report highlights that "malignant centrofacial granulomatosis" may be a peripheral T-cell lymphoma, potentially linked to Epstein-Barr virus (EBV).
Area of Science:
- Pathology
- Oncology
- Infectious Disease
Background:
- Accurate diagnosis of destructive centrofacial lesions is clinically challenging.
- The entity previously termed "malignant centrofacial granulomatosis" presents diagnostic difficulties.
- Peripheral T-cell lymphomas can manifest as aggressive facial infiltrative processes.
Observation:
- A case of an 83-year-old male with a destructive centrofacial process is presented.
- The patient was diagnosed with angiocentric peripheral T-cell lymphoma.
- The clinical presentation mimicked other inflammatory or infectious destructive lesions.
Findings:
- The reported case underscores the potential misclassification of destructive centrofacial lesions.
- Angiocentric peripheral T-cell lymphoma can present as a centrofacial destructive process.
- Epstein-Barr virus (EBV) is implicated as a potential pathogenic factor in this context.
Implications:
- This case highlights the importance of considering hematologic malignancies in the differential diagnosis of facial destruction.
- Recognition of EBV's role may influence diagnostic and therapeutic strategies.
- Improved diagnostic criteria are needed to differentiate T-cell lymphoma from granulomatous diseases.